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Telomerase activity in human cells closely correlates with the expression of its catalytic subunit, telomerase reverse transcriptase
(hTERT). Previously, we reported the lack of telomerase activity in normal human oral fibroblasts (NHOF) and the diminution of
telomerase activity during senescence in normal human oral keratinocytes (NHOK). To investigate the underlying mechanisms of
telomerase regulation in both cell types, we analysed the expression, promoter activity, and methylation status of the hTERT gene.
The expression of hTERT mRNA diminished in senescent NHOK, but was not detected in NHOF at any stage of replication. An
exogenous hTERT promoter was active in NHOF and in senescing NHOK, indicating that the lack of hTERT gene expression resulted
from alteration of the endogenous hTERT promoter. Since methylation is involved in the silencing of numerous genes, we carried out
DNA methylation assays. The assay revealed that the hTERT promoter was hypermethylated in NHOF and was gradually methylated
during senescence in NHOK. Treatment of NHOF and senescent NHOK with the demethylating agent 5-aza-20-deoxycytidine
restored the expression of endogenous hTERT mRNA. Our results suggest that hypermethylation of the hTERT promoter plays a
critical role in the negative regulation of telomerase activity in normal human oral cells.
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Telomerase is complex, composed of a ribonucleoprotein, reverse
transcriptase catalytic subunit, hTERT, template, hTR, and several
associated protein cofactors (Feng et al, 1995; Harrington et al,
1997; Meyerson et al, 1997; Nakamura et al, 1997). While hTERT is
not expressed in most normal human somatic tissues, hTR is
expressed constitutively in most human tissues (Kim et al, 1994;
Shay and Bacchetti, 1997). In normal human cells and in tumour
cells, telomerase activity is positively correlated with the expres-
sion of hTERT (Kim et al, 1994; Shay and Bacchetti, 1997).
Therefore, regulation of hTERT expression appears to control
telomerase activity. The hTERT promoter region has been cloned
and characterised (Horikawa et al, 1999; Takakura et al, 1999),
permitting analysis of the molecular mechanisms involved in its
regulation (Cong et al, 1999; Horikawa et al, 1999; Takakura et al,
1999; Wick et al, 1999). Transcription factors c-myc, Sp1, AP2,
AP4, and c-myb act as activators and several repressors, such as
WT1, p53, MZF-2, and Mad1, have been identified (reviewed by
Poole et al, 2001). Analysis of the hTERT promoter region also
revealed the presence of CpG islands containing CG-rich methyla-
tion sites (Cong et al, 1999; Horikawa et al, 1999; Takakura et al,
1999; Wick et al, 1999). Promoter region hypermethylation
associated with transcriptional loss is an alternative mode of gene
silencing for several tumour-suppressor genes (Zingg and Jones,
1997; Baylin et al, 1998; Herman, 1999). The hypermethylation
status of the hTERT promoter has been examined in a variety of
human normal and cancer cells (Devereux et al, 1999; Dessain et al,
2000; Guilleret et al, 2002). In these studies, hTERT promoter
methylation was observed in telomerase-negative, as well as in
telomerase-positive cells, suggesting different modes of regulation
of hTERT expression in methylation-dependent and -independent
pathways.
Previously, we reported that replicating normal human oral
keratinocytes (NHOK) expressed telomerase activity, which
gradually disappeared during senescence, and that normal human
oral fibroblasts (NHOF) lacked telomerase activity at all stages of
replication (Kang et al, 1998). To investigate the mechanism of
telomerase inactivation in NHOK and NHOF, we analysed the
changes in hTERT expression, hTERT promoter activity, and
methylation status of the hTERT promoter, in serially subcultured
NHOK and in replicating NHOF. In our present study, we found
that the inactivity of telomerase in NHOF and during NHOK
senescence was not caused by absence or defective necessary
cofactors, but by hypermethylation of CpG islands in the hTERT
gene promoter.
MATERIALS AND METHODS
Cells and culture conditions
Primary cultures of NHOF were established from explants of the
gingival connective tissue excised from patients undergoing oral Received 3 March 2003; revised 14 July 2003; accepted 24 July 2003
*Correspondence: Dr N-H Park, UCLA School of Dentistry, CHS 53-
038, 10833 Le Conte Ave. Los Angeles, CA 90095-1668, USA;
E-mail: npark@dent.ucla.edu
British Journal of Cancer (2003) 89, 1473–1478
& 2003 Cancer Research UK All rights reserved 0007– 0920/03 $25.00
www.bjcancer.com
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
ysurgery. The cells that proliferated outwardly from the explant
culture were continuously cultured in 100-mm culture dishes, in
DMEM/medium 199 (4:1) containing foetal bovine serum (Gemini
Bioproducts, Calabasas, CA, USA), and gentamicin (50mgml
 1).
Primary NHOK were prepared from separated epithelial tissue,
and serially subcultured in keratinocyte growth medium (KGM,
Clonetics, Charlotte, NC, USA) containing 0.15mM Ca
2þ,a s
described previously (Kang et al, 1998). Adenovirus transformed
human embryonic kidney cells 293, obtained from the American
Type Culture Collection (Manassas, VA, USA), were cultured in
DMEM/medium 199 (4:1) containing foetal bovine serum (Gemini
Bioproducts) and gentamicin (50mgml
 1). SCC-4 (human squamous
cell carcinoma cell line) was obtained from American Type Culture
Collection (Manassas, VA, USA), and cultured in DMEM/Ham’s F-12
containing 10% foetal bovine serum (Gemini Bioproducts) and
gentamicin (50mgml
 1).
Cell population doublings (PD) were determined after sub-
culturing to postmitotic stage. At the end of each passage, PD was
calculated by the formulation, 2
N¼(Cf/Ci), where N denotes PD,
Cf the total cell number harvested at the end of a passage, and Ci
the total cell number of attached cells at seeding. The PD time was
calculated by dividing the duration of culture in hours by the
number of PD.
Analysis of telomerase activity
Cellular extracts were prepared by using CHAPS (lysis buffer)
provided from the TRAP-eze Telomerase Detection Kit (Intergen
Norcross, GA, USA), as recommended by the manufacturer.
Telomerase activity was determined using the TRAP-eze Telomerase
Detection Kit as described previously (Kang et al,1 9 9 8 ) .E a c hT R A P
reaction contained a cellular extract equivalent to 1mgp r o t e i n .T h e
PCR products were electrophoresed in 12.5% nondenaturing
polyacrylamide gels, and the radioactive signals were detected by
PhosphorImage (Molecular Dynamix, Sunnyvale, CA, USA).
Analysis of endogenous hTERT expression
Total RNA was isolated from the cells using Trizolt reagent
(Invitrogen Carlsbad, CA, USA) and further purified through
RNeasy columns (Qiagen, Chatsworth, CA, USA). Following
isolated RNA solution in 7.5mlH 2O, the reverse transcription
(RT) reaction was performed in first-strand buffer (Invitrogen)
containing 200U Superscript II (Invitrogen), 40U RNase inhibitor
(Perkin-Elmer, Foster City, CA, USA), 10mM dithiothreitol, 250ng
random hexamer (Perkin-Elmer), and 2.5mM dNTP. The annealing
reaction was carried out for 10min at 251C, and cDNA synthesis
was performed for 50min at 421C, followed by 10min incubation
at 701C for enzyme inactivation.
To amplify hTERT cDNA, PCR reaction was performed with 1ml
RT product using the primers 50-GCCTGAGCTGTACTTTGTCAA-
30 (forward) and 50-CGCAAACAGCT TGTTCTCCATGTC-30 (re-
verse). The primer set amplified hTERT mRNA species encoding
functional full-length (457bp) or defective spliced isoforms (421,
275, or 239bp) (Ding et al, 2002). PCR products were separated in
2% agarose gels. The hTERT signals were further amplified by
Southern hybridisation using
32P-[dCTP]-radiolabelled probe
synthesised from hTERT cDNA, as described in detail previously
(Kang et al, 2002).
Analysis of hTERT promoter activity
A pGL3B-TRTP containing a 1670bp fragment ( 1665 to 5) of full-
length hTERT promoter upstream of the firefly luciferase gene in
the pGL3-basic (Promega Madiso, WI, USA), kindly provided by
Dr J Carl Barrett (National Institute of Environmental Health
Science), was used for the hTERT promoter assay. Prior to
transfection, a six-well plate with approximately 5 10
4 cells per
well was inoculated and cultured for 24h. The pGL3-basic
(2mgwell
 1) or the pGL3B-TRTP vectors (2mgwell
 1) were
transfected using Lipofectin reagent (BRL Life Technologies, Inc.,
Gaithersberg, MD, USA). For better comparison among cells with
different transfection efficiencies, the pGL3-control plasmid
(2mgwell
 1; Promega), which has the firefly luciferase gene under
the transcriptional control of SV40 enhancer/promoter, was also
transfected into each cell and used for normalisation of the
activities shown by the pGL3B-TRTP construct. Cells were
collected 48h after transfection and cell lysates prepared according
to Promega’s instruction manual. Luciferase activity was measured
using a luminometer (Promega).
Methylation analysis of hTERT promoter
Methylation of the hTERT promoter was studied using methyla-
tion-specific PCR with bisulphite-modified DNA and 5-aza-20-
deoxycytidine (5-aza-CdR) treatment (Dessain et al, 2000). For
methylation-specific PCR with bisulphite-modified DNA, genomic
DNAs from cells were isolated using Qiagen Tissue/Blood Kit
(Qiagen), and bisulphite-modified according to published methods
(Dessain et al, 2000). Promoter regions of hTERT were amplified
from the nonmodified and the modified DNA. PCR reaction
products were electrophoresed in 2% agarose and amplified DNA
fragments were directly visualised under UV illumination.
Cells were incubated in the culture medium with 10mM 5-aza-
CdR for 24h on days 3 and 5, and then harvested on day 7 for
analysis. Total RNA was prepared using Trizolt reagent (Invitro-
gen). Randomly primed cDNAs were reverse-transcribed and
hTERT cDNA was amplified as described above.
RESULTS
Correlation between the expression of endogenous hTERT
and telomerase activity in NHOF and NHOK
Our previous studies have shown the absence of telomerase
activity in NHOF, its presence in exponentially replicating NHOK,
and its gradual diminution during senescence in NHOK (Kang
et al, 1998). This finding was confirmed in the present investiga-
tion, subjecting the exponentially replicating NHOF and NHOK,
and senescent NHOK, to the telomeric repeat amplification
(TRAP) assay (Figure 1A). Telomerase activity was not detected
in replicating NHOF or in senescing NHOK, but was detected in
exponentially proliferating NHOK (Figure 1).
The regulation of telomerase activity by expression of the
hTERT gene was confirmed. The expression of full-length and
splicing variants of hTERT was also determined using primers
flanking the RT domain of hTERT (Ding et al, 2002). The full-
length hTERT mRNA containing the functional RT domain was
detected in exponentially replicating NHOK as a 457bp band
(Figure 2). The spliced variant of hTERT mRNA, also known as the
b-deletion transcript containing a nonfunctional RT domain, was
also identified in exponentially replicating NHOK as a 275bp band
(Figure 2). The b-deletion transcript causes a 183bp deletion
(bases 2342–2524) resulting in nonsense mutation, truncating the
hTERT protein before the conserved RT motifs (Ulaner et al,
1998). hTERT mRNA was not detected in replicating NHOF or
senescent NHOK which lacked telomerase activity (Figure 2). The
presence of hTR mRNA in all tested cells indicated that hTR was
not the limiting factor of the telomerase activity in NHOF and
senescent NHOK (Figure 2).
Transcriptional activity of an exogenous hTERT promoter
in NHOF and NHOK
The absence of hTERT mRNA in NHOF and senescent NHOK
could result from either one of the following forms of negative
hTERT methylation in normal human oral cells
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region or (2) defect in trans-acting regulatory factors required for
promoter activity. To distinguish between the two possibilities, we
examined the transcriptional activity of an exogenous hTERT
promoter in NHOF and NHOK. SCC-4, a telomerase-positive
human oral cancer cell line, served as positive control (Kang et al,
1998). The pGL3B-TRTP luciferase reporter plasmid containing a
full-length hTERT promoter (nucleotides  1665 to þ5) was
transiently transfected into cells. The luciferase activity of pGL3B-
TRTP was measured and compared with that of the pGL3-control
plasmid, which was driven by the SV40 enhancer/promoter and
used to monitor the transfection efficiency (Horikawa et al, 1999;
Takakura et al, 1999).
As shown in Table 1, the pGL3B-TRTP plasmid expressed
luciferase activity, that is, 9.8% of the pGL3-control, in the
telomerase-positive human oral cancer cell line SCC-4. The same
level of activity was found in exponentially replicating (PD 10) and
senescing (PD 20) NHOK (7.0 and 6.9%), respectively. A similar
level of activity (10.9% of the pGL3-control) was detected in
hTERT-negative NHOF. These findings indicate that the necessary
factors for hTERT expression were present and active in NHOF
and senescent NHOK. It also suggests that negative alteration of
the hTERT promoter is involved in repression of endogenous
hTERT expression.
Methylation of the hTERT promoter in NHOF and
senescent NHOK
Previous studies have shown that (1) promoter hypermethylation
is frequently associated with gene silencing (Herman et al, 1999),
(2) the telomerase gene has a typical CpG island domain for
methylation in its promoter (Horikawa et al, 1999; Takakura et al,
1999), and (3) the human hTERT gene promoter is hypermethy-
lated in cells with reduced telomerase activity (Devereux et al,
1999; Bechter et al, 2002). These findings suggested that the
absence of hTERT gene expression in NHOF and senescent NHOK
might be due to hypermethylation of the endogenous hTERT
promoter. In the hTERT promoter, two CpG islands, the
transcription start site and regions 30 to the translation start site,
have been well characterised (Cong et al, 1999; Horikawa et al,
1999; Takakura et al, 1999; Dessain et al, 2000). Therefore, it was
possible to determine the presence of methylation in both CpG
islands in NHOF and senescent NHOK by using bisulphite
treatment of DNA and subsequent methylation-specific PCR
(Dessain et al, 2000).
In NHOF, as shown in Figure 3, the region 30 to the translation
start site (TL) was completely methylated, while the region 30 to
the transcription start site (TC) was not methylated (Figure 3A).
In rapidly proliferating NHOK (PD 11) that expressed
hTERT mRNA and telomerase activity, both CpG islands in the
hTERT promoter were hypomethylated (Figure 3B). Senescing
NHOK (PD 20) showed methylation in both CpG islands
(Figure 3C). With a reduced number of PCR cycles (15 cycles),
the fraction of cells containing the methylated promoter was
greater than that of cells containing the unmethylated promoter
(Figure 3C). The methylation status of the hTERT promoter in the
telomerase-positive cell line SCC-4 was also examined. Both CpG
islands in the hTERT promoter were not methylated in the cell line
(Figure 3D).
Introduction of endogenous hTERT expression in NHOF
and senescing NHOK exposed to 5-aza-CdR
We investigated whether hypermethylation was solely responsible
for repression of the hTERT gene expression by exposing the cells
to 5-aza-CdR, the potent demethylating agent (Bender et al, 1998).
The concentrations of 5-aza-CdR utilised in the present study were
based on the studies reported by others (Devereux et al, 1999;
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Figure 1 (A) TRAP assay of NHOK and NHOF. Cellular extracts
obtained after different PD were tested for telomerase activity. The
positive control was 293 (adenovirus-transformed human embryonic
kidney cells). The CHAPS buffer was used as a negative control. IC is an
internal control amplification product provided in the assay kit. We
repeated this experiment three times with NHOF and NHOK cultures
derived from different donors and obtained similar results (data not
shown). (B) Replicative lifespan of NHOK. The cell PD were calculated as
described in Materials and Methods. NHOK at PD 15 and PD 20 were
used for the TRAP assay.
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Figure 2 Expression of hTERT and hTR mRNA in NHOK and NHOF.
Three different NHOK cultures (NHOK-1, NHOK-2, and NHOK-3) and
two different NHOF cultures (NHOF-1 and NHOF-2) from various
donors were examined in this experiment. The level of hTERT mRNA was
detected by RT–PCR and subsequent Southern blotting with
32P-labelled
full-length hTERT cDNA. A full-length (457bp) and spliced isoform
(275bp) of hTERT mRNA was detected in rapidly replicating NHOK.
The level of hTR mRNA was determined by RT–PCR. b-Actin mRNA was
amplified as a control.
hTERT methylation in normal human oral cells
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effect of 5-aza-CdR (at a range of 1–10mM) in exponentially
proliferating NHOF and NHOK for up to 3, 7, or 10 days, and
found that 1 or 5mM of 5-aza-CdR did not demonstrate any
cytotoxic effect in these cells during the 7-day period, by
determining the proliferation rate of cells as described elsewhere
(Kang et al, 2000). NHOF and senescing NHOK were cultured in
the absence or presence of 5mM 5-aza-CdR for 3, 5, and 7 days, and
hTERT gene transcription was tested by RT–PCR Southern
blotting (Figure 4).
After 5 days of treatment, NHOF expressed a full-length (457bp)
and a spliced isoform (275bp) of hTERT mRNA, whose expression
was maintained during the entire 7-day treatment (Figure 4A).
Senescing NHOK after 3 days of treatment with 5-aza-CdR
re-expressed a full-length (457bp) and a spliced variant (275bp)
of hTERT mRNA (Figure 4B). With longer exposure of the gel, the
full-length hTERT mRNA was clearly visible in the 5-aza-CdR-
treated NHOK (data not shown). Telomerase activity tested by the
TRAP assay was not detected in NHOF and senescing NHOK
exposed to 5-aza-CdR (data not shown). These results suggest that
hTERT promoter hypermethylation in NHOF and senescent NHOK
is linked to gene silencing, which can be reversed by demethyla-
tion.
DISCUSSION
Activation of telomerase activity is thought to be a critical step in
cellular immortalisation and transformation. Since telomerase
activity is primarily regulated through hTERT expression, under-
standing of hTERT regulation in normal cells is crucial for the
understanding of carcinogenesis. Our present studies provide
evidence that methylation of the hTERT promoter is responsible
Table 1 Exogenous hTERT promoter activity in NHOK, NHOF, and senescing NHOK
Luciferase activity (light units)
a
Cells Telomerase activity pGL3-basic (no promoter) pGL3B-TRTP (hTERT promoter) pGL3-control (SV40 promoter)
SCC-4
b + 1.770.5 (0.03%) 610761 (9.8%)
c 62417825 (100%)
NHOK (PD 10) + 0.0170.02 (0%) 244713 (7%) 35077113 (100%)
NHOK (PD 20)   0.00470.002 (0%) 60.7723 (6.9 %) 878732 (100%)
NHOF (PD 24)   0.0170.02 (0%) 11574 (10.9%) 10597148 (100%)
aMean luciferase activity and standard deviation. The activity of pGL3-basic or pGL3B-TRTP was normalised with that of pGL3-control.
bSCC-4, telomerase-positive human
squamous cell carcinoma cell line.
cPercentage of pGL3-control.
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NHOK (PD 20)
NHOK (PD 11)
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SCC-4
A B
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D
Figure 3 Methylation-specific PCR of the hTERT CpG islands in NHOF
and NHOK. Genomic DNA was treated with bisulphite and tested with
transcription start site (TC) and translation start site (TS) primer sets
specific for either unmethylated (U) or methylated (M) hTERT promoter.
(A) Methylation status of hTERT promoter in rapidly replicating NHOF (PD
18). The promoter was amplified with 25 cycles. (B) Methylation status of
hTERT promoter in rapidly replicating NHOK (PD 15). The promoter was
amplified with 25 cycles. (C) Methylation status of hTERT promoter in
senescent NHOK (PD 20). The promoter was amplified with 15 or 25
cycles. (D) Methylation status of hTERT promoter in SCC-4. The promoter
was amplified with 25 cycles.
3D 5D 7D
− + − + − +
−− −+ − +
A
B
Aza
Aza
NHOF (PD 24)
PD 12 19 19 19 19 19
NHOK
hTERT (457 bp)
hTERT (275 bp)
−actin (220 bp)
hTERT (457 bp)
hTERT (275 bp)
−actin (220 bp)
3D 5D
Figure 4 (A) Re-expression of endogenous hTERT mRNA in rapidly
replicating NHOF (PD 24) exposed to 5-aza-CdR. (B) Re-expression of
endogenous hTERT mRNA in senescent NHOK (PD 19) exposed to 5-aza-
CdR. The cells were treated with 5mM of 5-aza-CdR for 3, 5, and 7 days
and analysed for hTERT mRNA expression using RT–PCR Southern
blotting. b-Actin mRNA was amplified as a control.
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telomerase activity in NHOF and senescent NHOK.
Transcriptional activation has been considered a major mechan-
ism for the regulation of the hTERT gene (Poole et al, 2001).
Consistent with previous observations (Kim et al, 1994; Shay and
Bacchetti, 1997), we found that expression of hTERT is a limiting
factor for telomerase activity in NHOF and NHOK. Also, the
presence of hTERT mRNA encoding functional or defective spliced
isoforms has been demonstrated in several types of normal and
pathogenic human cells (Ulaner et al, 1998, 2000; Liu et al, 1999).
The splicing pattern of hTERT mRNA has been considered part of
a regulatory mechanism for telomerase activity, but the details are
unknown (Kilian et al, 1997; Ulaner et al, 1998, 2000; Wick et al,
1999). The b-deletion transcript causes premature termination of
translation, resulting in truncation of the protein, and has been
observed in various cell types (Nakamura et al, 1997; Wick et al,
1999; Ding et al, 2002). In the present study, we have detected the
full-length and the b-deletion transcripts of hTERT in normal oral
keratinocytes. Similar to our observations, coexpression of the full-
length and the b-deletion transcripts have been reported in normal
ovarian tissues (Ulaner et al, 2000) and human papillomavirus-
immortalised endocervical cells (Ding et al, 2002). According to a
previous report (Yi et al, 2001), a b-deletion splice variant was
dominantly expressed (80–90% of total hTERT mRNA) in various
human epithelial cells. Since NHOK is an epithelial cell, the
domination of the b-deletion splice variant is not surprising.
Although the reason for the dominant reactivation of the b-
deletion splice variant upon the 5-aza-CdR treatment is not
known, we could not rule out the possibility that the half-life
(stability) of the b-deletion splice variant is longer than the full-
length hTERT mRNA, and autosecretion of TGF-b retains high
expression of the inactive b-deletion splice variant in NHOK
culture (Cerezo et al, 2002).
After testing the transcriptional activity of an exogenous hTERT
promoter in NHOF, rapidly proliferating NHOK and senescent
NHOK, we found significant transcriptional activity in all tested
cells, regardless of the presence of telomerase activity. The
promoter region (nt –1665 to þ5) examined in this study
included the 59bp region (nt  208 to  150) that was responsible
for the maximal promoter activity (Horikawa et al, 1999). The data
showed that in NHOF and senescing NHOK: (1) the transcriptional
machinery necessary for hTERT promoter activity in replicating
NHOF functioned as well as in NHOK-expressing hTERT mRNA
and (2) the transcriptional machinery necessary for the hTERT
promoter activity was not activated or inactivated during
senescence in NHOK. Therefore, the absence of hTERT expression
does not appear to be caused by a defective transcriptional
machinery, but by an altered endogenous hTERT promoter.
In contrast with other reports of unmethylated hTERT
promoters in normal fibroblasts (Devereux et al, 1999; Dessain
et al, 2000), our studies show that hTERT expression appears to be
correlated with the methylation status of the promoter in NHOF,
suggesting that promoter methylation does provide a means to
regulate hTERT expression in cells. To rule out the possibility of
experimental errors and donor variation, we performed two assays
in three strains of NHOF from different donors and obtained
consistent reproducible results. Therefore, the hTERT promoter is
tissue-specifically methylated and silenced in normal human
fibroblasts (Imamura et al, 2001; Shiota et al, 2002).
Previously, we reported that replication arrest preceded
differentiation in NHOK serially subcultured in vitro (Kang et al,
2000). The silencing of hTERT during squamous cell differentia-
tion was demonstrated (Harle-Bachor and Boukamp, 1996).
Based on these observations, we speculate that the silencing of
hTERT due to promoter methylation is also in part associated with
the silencing of hTERT during squamous differentiation in vivo.
Hypermethylation of the hTERT promoter during senescence in
normal oral keratinocytes was correlated with the diminution of
telomerase activity and hTERT mRNA expression. The involve-
ment of promoter methylation in hTERT gene regulation during
senescence in oral keratinocytes was further confirmed by
induction of hTERT expression in senescent NHOK exposed to
5-aza-CdR. This finding supported the concept that the differ-
entiation of cells is associated with changing methylation status at
many loci in the genome (Shiota et al, 2002). While hTERT
expression was restored by exposure to 5-aza-CdR, telomerase
activity was not. Although the reason for inability of the chemical
to restore telomerase activity is not known, we speculate that the
inhibitory effect of 5-aza-CdR on DNA synthesis and telomerase
activity may be the cause. 5-aza-CdR inhibited both DNA synthesis
and telomerase activity in exponentially replicating NHOK (our
unpublished data).
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